Auburn University College of Veterinary Medicine

Annette N. Smith, DVM, MS, DACVIM

Oncology

Dr. Smith completed 3 years of a Biomedical Science program at Texas A&M prior to admission to the DVM program at Texas A&M's College of Veterinary Medicine. She graduated with honors in May 1994. Her interest in internal medicine and oncology had been piqued as a senior veterinary student, and during her internship at the University of Illinois, she decided to pursue residency training in both specialties, and joined Auburn University's program in 1995. She was certified in both internal medicine and oncology in May 2000. While pusuing her residency training, she also completed requirements for a Master's degree in Biomedical Sciences, and received her diploma in December 2001. She served on the Auburn University faculty as an assistant Clinical Professor from 1999-2000, an Assistant Professor from 2000-2005, and is currently an Associate Professor. She coordinates Auburn University's oncology program, which focuses on a multidisciplinary team approach to each patient.

334-844-4690
smith30@auburn.edu

Research Interests

Angiogenesis, hemangiosarcoma, thymoma, intracavilary chemotherapy, gene therapy for osteosarcoma and lymphosarcoma.

Selected Publications

Smith AN. Practical matters: Things to remember to calculate chemotherapy dosages correctly. Veterinary Medicine pgs 101:638, 2006.

Bryan JN Henry CJ, Turnquist SE, Tyler JW, Rizzo SA, Sfiligoi G, Steinberg SJ, Smith AN, Jackson T. Primary renal neoplasia of dogs. J Vet Intern Med 20:1155-1160, 2006.

Boozer AL, Behrend EN, Kemppainen RJ, Whitley EM, Smith AN, Busch KA. Hypothalamic-pituitary-adrenal axis function in dogs with neoplasia, Veterinary and Camparative Oncology pgs 194-202, 2005.

Smith AN. Hemangiosarcoma in dogs and cats. Standards of Care: Emergency and critical care medicine 7.10:1-6, 2005.

Chun R, Garrett LD, Wall M, Smith A, Azene NM. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. J Am An Hosp Assoc 41:382-387, 2005.

Behrend EN Kemppainen RJ, Boozer AL, Whitley EM, Smith, AN Busch KA. Serum 17-alpha-hydroxyprogesterone and corticosterone concentrations in tumor-bearing dogs and dogs with suspected hyperadrenocorticism, J Am Vet Med Assoc 227:1762-1767, 2005.

Smith AN, Burke H, Heatley JJ, Beard D, Blue JT, Weiss RC. Chemotherapy for lymphosarcoma in a mouse. Exotic DVM 6.5, 2005.

Cohen M, Sartin EA, Whitley EM, Whitley RD, Brawner WR, Smith AN, Henderson RA, Behrend EN. Ocular metastasis of a vaccine-associated fibrosarcoma in a cat. J Comparative Oncol 1:232-240, 2003.

Axlund TW, McGlaason ML, Smith AN. Treatment of intracranial meningiomas in the dog with surgery alone or in combination with irradiation (1989-2002). J Am Vet Med Assoc 221:1597-1600, 2002.

Smith AN, Wright JC, Brawner WR, LaRue SM, Fineman L, Hoggenjaus AE, Burk RL, Dhalwal RS, Duda LE. Radiation therapy in the treatment of canine and feline thymomas: a retrospective study (1985-99), J Am Anim Hosp Assoc 37:489-96, 2001.

Cohen M, Wright JC, BrawnerWR, Smith AN, Henderson RA, Behrend EN. Use of surgery and electron beam radiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996-2000), J Am Vet Med Assoc 219:1582-89, 2001.

Smith AN, Spencer J, Stringfellow J, Vygantes K, Welch J. Disseminated Phialemonium obovatum in a German shepherd dog. J Am Vet Med Assoc 216:708-712, 2000.

Smith AN, Dillon AR, Finn-Bodner ST. Left ventricular outflow tract to left atrial fistula associated with endocarditis in a dog. J Am Anim Hosp Assoc 36:133-136, 2000.

Henry CJ, Turnquist SE, Smith A, Graham JC, Thamm DH, O'Brien M, Clifford CA. Primary renal tumors in cats: 19 cases (1992-1998). J Feline Med & Surg pgs 165-170, 1999.